Company name Merck & Co., Inc. Stock ticker MRK Live stock price [[MRK]] P/E compared to competitors Good MANAGEMENT EXECUTION Employee productivity Fair Sales growth Poor EPS growth Good P/E growth Good EBIT growth Good ANALYSIS Confident Investor Rating Good Target stock price (TWCA growth scenario) $98.03 Target stock price (averages with growth) $80.89 Target […]
At this price and at this time, I think that a Confident Investor can confidently invest in Merck & Co., Inc.
The German company is pinning its health care hopes on successfully developing its anti-PDL1 immuno-oncology treatment in alliance with Pfizer. That puts the pharmaceutical and materials company in one of the hottest, but also most competitive, areas in health care. And Merck doesn’t have an obvious edge. Merck’s [[MRK]] first-quarter results Tuesday showed its challenges. […]
The market was generally good last week and should be good this week as well. More concern is on geo-political events that could cause a pullback. There is a very good chance that the week will be flat so individual stock choices will be important.
We seem to be stuck in a bit of a holding pattern for now. I continue to stress that it is very important as to the stocks that you choose to have in your portfolio.